These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The effects of atorvastatin on interventional therapy in patients with acute myocardial infarction. Wang K; Chen L; Liu L; Cui Y; Zhang X; Jiang J Minerva Med; 2019 Apr; 110(2):101-106. PubMed ID: 29696937 [TBL] [Abstract][Full Text] [Related]
7. Achieving vascular risk factor targets: a survey of a London general practice. Levine AP; Mikhailidis DP; Moross T; Benson K; Gor M Angiology; 2008; 59(1):36-46. PubMed ID: 18319220 [TBL] [Abstract][Full Text] [Related]
8. Association between periodontal disease and acute myocardial infarction. Emingil G; Buduneli E; Aliyev A; Akilli A; Atilla G J Periodontol; 2000 Dec; 71(12):1882-6. PubMed ID: 11156045 [TBL] [Abstract][Full Text] [Related]
9. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting. Cziraky MJ; Watson KE; Talbert RL J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279 [TBL] [Abstract][Full Text] [Related]
10. Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment. Ansell BJ; Navab M; Hama S; Kamranpour N; Fonarow G; Hough G; Rahmani S; Mottahedeh R; Dave R; Reddy ST; Fogelman AM Circulation; 2003 Dec; 108(22):2751-6. PubMed ID: 14638544 [TBL] [Abstract][Full Text] [Related]
11. Lipid modifying action of atorvastatin in comparison to combination of atorvastatin and nicotinic acid in patients with ischaemic heart disease. Santanu G; Suhrita P; Mookerjee S; Tania K; Mita S; Pramit G; Sharmila G; Miraj M; Debdutta M Indian Heart J; 2011; 63(5):434-7. PubMed ID: 23550422 [TBL] [Abstract][Full Text] [Related]
12. Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Amarenco P; Goldstein LB; Callahan A; Sillesen H; Hennerici MG; O'Neill BJ; Rudolph AE; Simunovic L; Zivin JA; Welch KM; Atherosclerosis; 2009 Jun; 204(2):515-20. PubMed ID: 18962621 [TBL] [Abstract][Full Text] [Related]
13. Impact of the statin escape phenomenon on long-term clinical outcomes in patients with acute myocardial infarction: Subgroup analysis of the Nagoya Acute Myocardial Infarction Study (NAMIS). Ota T; Ishii H; Suzuki S; Shibata Y; Tatami Y; Harata S; Shimbo Y; Takayama Y; Tanaka A; Kawamura Y; Osugi N; Maeda K; Kondo T; Murohara T Atherosclerosis; 2015 Sep; 242(1):155-60. PubMed ID: 26188539 [TBL] [Abstract][Full Text] [Related]
14. An exploratory study examining lipid-lowering medications in reducing fasting serum lipids in schizophrenia patients treated with atypical antipsychotics. Vincenzi B; Borba CP; Gray DA; Copeland PM; Wang X; Fan X; Aragam GG; Henderson DC Ann Clin Psychiatry; 2013 May; 25(2):141-8. PubMed ID: 23638445 [TBL] [Abstract][Full Text] [Related]
15. Effects of increasing high-density lipoprotein cholesterol and decreasing low-density lipoprotein cholesterol on the incidence of first acute coronary events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study). Cui Y; Watson DJ; Girman CJ; Shapiro DR; Gotto AM; Hiserote P; Clearfield MB Am J Cardiol; 2009 Sep; 104(6):829-34. PubMed ID: 19733719 [TBL] [Abstract][Full Text] [Related]
16. Differences in physician compliance with guideline on lipid profile determination within 24 h after acute myocardial infarction. Al Aqeel A; Mojiminiyi OA; Al Dashti R; Al Ozairi ES Med Princ Pract; 2005; 14(1):41-5. PubMed ID: 15608480 [TBL] [Abstract][Full Text] [Related]
17. Attainment of normal lipid levels among patients on lipid-modifying therapy in Hong Kong. Ambegaonkar B; Chirovsky D; Tse HF; Lau YK; Tomlinson B; Li SK; Yue CS; Wong TH; Choi MC; Tunggal P; Sazonov V Adv Ther; 2012 May; 29(5):427-41. PubMed ID: 22562782 [TBL] [Abstract][Full Text] [Related]
18. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels. Querton L; Buysschaert M; Hermans MP J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779 [TBL] [Abstract][Full Text] [Related]
19. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly. Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195 [TBL] [Abstract][Full Text] [Related]
20. Physicochemical modifications induced by statins therapy on human erythrocytes membranes. Broncel M; Bała A; Koter-Michalak M; Duchnowicz P; Wojsznis W; Chojnowska-Jezierska J Wiad Lek; 2007; 60(7-8):321-8. PubMed ID: 18175550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]